← Today’s ReceiptsSource pending
Public-record receiptD-WASource pending
Emily Randall disclosed SELL $AMGN
Here’s the public record: who traded, what they disclosed, when it happened, how late it appeared, and what context is attached.
Trade range
$1K – $15K
Filed
2025-02-11
Trade date
2025-01-06
Disclosure lag
36 days after trade
Why this receipt matters
A quick read before you share it.
These are factual context points from the receipt and linked public-record data. They explain why the disclosure may be worth opening, not whether anyone acted improperly.
1The disclosure is tracked with source status pending, so treat it as a record to verify rather than a finished source trail.
2The filing appeared 36 days after trade, which helps separate trade timing from filing timing.
3The disclosed range is $1K – $15K, which is the public reporting band rather than an exact profit or loss figure.
44 nearby same-ticker disclosures appeared in the surrounding 30-day window.
5Committee context is available for Emily Randall, but PoliWealth treats it as context - not proof of intent or wrongdoing.
6Related public-record context includes 12 lobbying filings.
Source
source pending
Source: indexed congressional disclosure; official source link pending · filed 2025-02-11 · disclosed 36d after transaction
Market context
Amgen Inc.
Sector: Healthcare
Vs SPY: 13.7%
Factual flags
- 12 lobbying filings linked to this ticker.
- 4 nearby same-ticker disclosures in the surrounding 30-day window.
Member trail
Emily Randall
U.S. House · WA-6
House Committee on Natural ResourcesHouse Committee on Oversight and Government Reform
Ticker trail
$AMGN
Amgen Inc.
Follow this tickerAlert me when this ticker gets a new congressional receipt. This page reports public disclosures and factual context only. It does not determine intent, is not an accusation, and is not investment advice.